Technical articles
Selection Strategies for Animal-Derived Serum, Functionalized Serum, and Non-Animal-Derived Culture Supplementation Systems in Cell Culture
Selection Strategies for Animal-Derived Serum, Functionalized Serum, and Non-Animal-Derived Culture Supplementation Systems in Cell Culture
The choice of a culture supplementation system determines the nutritional supply, adhesion support, stress buffering, and signaling background available to cells, and directly affects the interpretability of experimental results, batch-to-batch consistency, and the feasibility of downstream scale-up. Animal-derived serum, functionalized serum, and non-animal-derived culture supplementation systems are not related by simple linear substitution, but instead represent different priorities in expansion efficiency, background control, and translational compatibility.
Keywords: cell culture; animal-derived serum; functionalized serum; non-animal-derived culture system; serum-free culture; chemically defined medium; xeno-free; culture supplementation system
1. Functional Basis of Culture Supplementation Systems
1.1 Nutritional Supply and Transport Support
(1) Basic nutritional components
Culture supplementation systems provide not only proteins and amino acids, but also lipids, trace elements, vitamins, low-molecular-weight metabolic substrates, and a variety of regulatory factors that promote cell proliferation and survival. For most cells, the supplementation system determines whether continuous division, membrane synthesis, and energy metabolic balance can be maintained.
(2) Transport of hydrophobic molecules and metal ions
Albumin, lipoprotein-like components, and certain carrier molecules can mediate the transport of lipophilic small molecules, buffer metal ions, and stabilize hydrophobic signaling molecules. This function is particularly important for cells that depend on lipid supply, cholesterol metabolism, and maintenance of membrane receptor signaling.
(3) Differences in nutrient availability
Different cell types vary markedly in their dependence on supplementation systems. Rapidly proliferating cells depend more on continuous protein and lipid supply, whereas primary cells and highly differentiated cells depend more on finely balanced signaling and stress buffering.
1.2 Adhesion, Survival, and Stress Buffering
(1) Adhesion support
Albumin, fibronectin-like factors, and other surface-active proteins in serum or alternative supplementation systems influence the spreading of adherent cells, membrane stability of suspension cells, and survival after low-density seeding.
(2) Operational protection
During trypsinization, thawing, centrifugation-based resuspension, and medium replacement, the supplementation system does not merely support growth, but also determines cellular tolerance to mechanical disturbance and membrane injury. Traditional serum-based systems generally have stronger buffering capacity in this respect.
(3) Stress buffering
Some supplementation systems can adsorb locally toxic molecules, residual enzymes, and surfactants generated during culture, while also buffering metabolic fluctuations. This is one reason why traditional serum-based systems often show relatively high fault tolerance under routine laboratory conditions.
1.3 Signaling Background and Phenotypic Shaping
(1) Background variables
A culture supplementation system does not merely support cell growth, but continuously influences cell phenotype. Hormones, cytokines, lipid ligands, exosome-like particles, and unidentified trace molecules may all alter proliferation rhythm, receptor expression, and differentiation tendency.
(2) Boundaries of interpretation
In mechanistic studies, omics analyses, and secretome research, the supplementation system is not external to the experimental background, but is itself an important determinant of the outcome. The more complex the system, the more variables are introduced, and the narrower the interpretive boundary becomes.
(3) Phenotypic stability
In stem cell, immune cell, primary cell, and engineered cell systems, high short-term viability alone does not prove that the culture condition is appropriate. The key question is whether the intended phenotype, transcriptional state, and functional output are maintained.
Table 1 Core Evaluation Dimensions of Culture Supplementation Systems
Evaluation Dimension | Main Focus | Direct Impact |
Proliferation support | Doubling time, rate of increase in cell density | Expansion efficiency, culture cycle |
Phenotypic stability | Morphological consistency, marker expression, differentiation tendency | Model reliability, experimental reproducibility |
Background complexity | Undefined proteins, small molecules, vesicles, and hormones | Pathway interpretation, omics analysis |
Batch consistency | Variation in composition and biological effect between batches | Stability of long-term projects |
Process compatibility | Suitability for scale-up, automation, and standardization | Pilot-scale work, manufacturing, translational research |
Biosafety | Animal-derived risk, pathogen background, immunogenicity | Regulatory compatibility and preclinical development |
2. Application Characteristics of Animal-Derived Serum Systems
2.1 Main Advantages of Animal-Derived Serum
(1) Breadth of compatibility
Animal-derived serum, especially fetal bovine serum (FBS), is broadly compatible with many common cell lines and some primary cells. During introduction of new cell types, before culture conditions are optimized, and during recovery after thawing, animal-derived serum can usually establish stable growth more rapidly.
(2) Culture fault tolerance
Animal-derived serum provides strong buffering support for adhesion, spreading, low-density seeding, medium replacement, and mechanical disturbance. For early method development and routine expansion, this fault tolerance often has clear practical value.
(3) Recovery-phase expansion
During the first few passages after thawing or in short-term expansion of unstable cells, animal-derived serum systems often yield more satisfactory viability and expansion rates than defined systems.
2.2 Main Limitations of Animal-Derived Serum
(1) Compositional complexity
Animal-derived serum contains large numbers of proteins, lipids, growth factors, hormones, cytokines, exosomes, and unknown trace components. This complexity confers broad support capacity, but also introduces substantial background variables.
(2) Batch variation
Different serum lots may differ markedly in growth support, induction of differentiation tendencies, and signaling background. For long-term projects or highly reproducible experiments, such variation often constitutes a major limitation.
(3) Interference in omics analyses
In transcriptomics, proteomics, metabolomics, exosome analysis, and secreted factor studies, the background contributed by animal-derived serum is often non-negligible. Many phenotypic changes are not caused solely by experimental treatment, but may result from the combined effect of treatment and serum background.
(4) Translational limitations
In cell therapy, clinical translation, and high-standard biomanufacturing, animal-derived components have inherent limitations in safety, regulatory acceptance, traceability, and consistency.
2.3 Typical Application Scenarios for Animal-Derived Serum
(1) Expansion of routine cell lines
For example, baseline expansion and method development in common cell lines such as HEK293, CHO, HeLa, and NIH/3T3.
(2) Exploration of culture conditions
Before the optimal supplementation system has been defined, animal-derived serum is often suitable as the initial culture condition.
(3) Recovery-phase conditioning
For example, post-thaw recovery, low-density plating, and short-term stabilization of newly isolated cells.
3. Application Characteristics of Functionalized Serum Systems
3.1 Basic Types of Functionalized Serum
(1) Low-endotoxin serum
Used to reduce endotoxin background and suitable for cell systems sensitive to inflammatory signaling, cytokine release, and stress responses.
(2) Dialyzed serum
Used to remove small-molecule metabolites, free nutrient components, and some low-molecular-weight background components, and suitable for metabolic studies and nutrient-dependence experiments.
(3) Charcoal-stripped serum
Used to remove steroid hormones and some lipophilic signaling molecules, thereby reducing hormonal background and making it suitable for nuclear receptor and hormone-dependent models.
(4) Exosome-depleted serum
Used to reduce vesicular background originating from serum and suitable for exosome, extracellular vesicle, and secretome studies.
(5) Heat-inactivated serum
Used to reduce complement activity and commonly applied in certain immune-related systems, though it may also weaken some beneficial bioactive components.
3.2 Application Value of Functionalized Serum
(1) Advantage in background control
The value of functionalized serum does not lie in being globally superior to conventional serum, but in the targeted control of a specific class of background interference.
(2) Role as a transitional system
For cells that cannot yet be directly switched to serum-free or non-animal-derived systems, functionalized serum is often a more realistic optimization pathway.
(3) Improved interpretability
In hormone studies, metabolic experiments, and exosome analyses, functionalized serum often has clearer experimental significance than conventional serum.
3.3 Limitations of Functionalized Serum
(1) Reduced growth support
Because some bioactive components are removed during processing, functionalized serum is usually weaker than conventional serum in supporting expansion and protecting cells.
(2) Process-related variability
Even within the same category of functionalized serum, differences among manufacturers or processing methods may lead to marked biological differences.
(3) Residual complexity
Functionalized serum improves background control, but does not fundamentally eliminate the complexity and uncertainty of animal-derived systems.
Table 2 Common Functionalized Serum Types and Their More Suitable Applications
Functionalization Type | Main Background Reduced | More Suitable Research Scenario | Main Limitation |
Low-endotoxin serum | Endotoxin background | Immune cells, inflammatory pathways, sensitive primary cells | Higher cost; cannot replace full-system optimization |
Dialyzed serum | Small-molecule metabolites and free nutrient components | Metabolic studies, nutrient-dependence experiments | Growth-promoting capacity may decline |
Charcoal-stripped serum | Hormones and lipophilic signaling molecules | Hormone receptor studies, nuclear receptor studies, ligand add-back experiments | Support capacity is usually weaker than that of conventional serum |
Exosome-depleted serum | Exosomes and vesicle-like particles | Exosome, extracellular vesicle, secretome studies | Depletion efficiency depends on the process |
Heat-inactivated serum | Complement activity | Certain immune-related culture systems | Some functional proteins may be damaged |
4. Application Characteristics of Non-Animal-Derived Culture Supplementation Systems
4.1 Main Types of Non-Animal-Derived Systems
(1) Serum-free culture systems
These systems do not necessarily exclude proteins entirely, but replace complex serum support with known components, making them suitable for improved background interpretability and process stability.
(2) Chemically defined culture systems
All key components have defined identities and controllable concentrations. Their greatest advantages are low background, clear variables, and high batch consistency.
(3) Xeno-free systems
These systems emphasize avoidance of components derived from non-target species and are commonly used in stem cell culture, cell therapy, and clinically oriented workflows.
(4) Recombinant protein and alternative supplementation systems
These include recombinant albumin, recombinant insulin, recombinant transferrin, growth factor combinations, lipid concentrates, and plant-derived hydrolysates, and can serve as non-animal-derived support modules.
4.2 Advantages of Non-Animal-Derived Systems
(1) Defined background
Once the system composition is defined, experimental outcomes can be more readily linked causally to specific treatment variables.
(2) Batch consistency
For long-term projects, repeated experiments across multiple batches, and process scale-up, defined systems are usually more stable than complex serum systems.
(3) Translational compatibility
Non-animal-derived systems offer clear advantages in regulatory acceptance, traceability, biosafety, and standardization.
4.3 Practical Challenges of Non-Animal-Derived Systems
(1) Differences in cellular adaptability
Routine cell lines are usually easier to adapt, whereas primary cells, stem cells, immune cells, and highly differentiated cells often require more refined formulation optimization.
(2) Adaptation effect
Transitioning from a serum-based system to a defined system is not simply a change of environment, but a process of cellular state rebalancing. Phenotypic changes introduced during adaptation should themselves be considered in interpretation.
(3) Formulation sensitivity
In defined systems, the concentrations and supplementation schedule of insulin, transferrin, lipids, and growth factors may all become decisive variables.
5. Key Comparison of the Three Categories of Systems
5.1 Proliferation Support and Morphological Stability
(1) Animal-derived serum systems
These systems usually make it easiest to achieve high expansion rates and good morphological recovery, but they also have the highest background complexity.
(2) Functionalized serum systems
While reducing specific background components, these systems usually retain some serum-like support capacity and are suitable as a compromise solution for particular research questions.
(3) Non-animal-derived systems
Once sufficiently optimized, these systems can achieve high consistency, but in the early stage they often show slower proliferation, insufficient adhesion, or a prolonged adaptation phase.
5.2 Background Control and Result Interpretation
(1) Animal-derived serum
Least favorable for experiments requiring low-background interpretability.
(2) Functionalized serum
Suitable for research settings in which the source of background interference is known and specifically targeted.
(3) Non-animal-derived systems
Most suitable for mechanistic studies, omics studies, and process standardization.
5.3 Translational and Scale-Up Compatibility
(1) Animal-derived serum
Suitable for early-stage method development, but clearly limited in clinical translation and high-standard manufacturing.
(2) Functionalized serum
More appropriate as a transitional option than as a final solution.
(3) Non-animal-derived systems
Most suitable for standardized scale-up and regulatory compatibility, though the upfront optimization cost is higher.
Table 3 Overall Comparison of the Three Categories of Culture Supplementation Systems
Comparison Dimension | Animal-Derived Serum | Functionalized Serum | Non-Animal-Derived Supplementation System |
Expansion support | Usually strong | Moderate to strong | Dependent on formulation optimization |
Background complexity | High | Moderate | Low |
Batch consistency | Relatively low | Moderate | Relatively high |
Suitability for mechanistic studies | Fair | Better | Best |
Suitability for primary/fragile cells | Often good | System-dependent | Requires dedicated optimization |
Suitability for scale-up and translation | Poor | Transitional | Best |
6. Products Related to Cell Culture Supplementation Systems
Table 4 Key Components Related to Chemically Defined and Non-Animal-Derived Supplementation Systems in Cell Culture
Name | CAS No. | System Category | Applicable Research Direction / Use | Notes for Use |
Bovine serum albumin (BSA) | Protein carrier / protective component | Suitable for providing protein buffering, lipid transport, and protection against cell-surface adsorption in serum-free or low-serum systems; can also reduce adhesion loss and shear stress | More suitable as a basic protective component and should not be used as a direct substitute for the full support functions of serum | |
Human serum albumin (HSA) | Human-derived protein supplement | Suitable for xeno-free or clinically oriented culture systems, replacing non-human animal-derived albumin and reducing xenogeneic background | More suitable for high-standard culture systems and translational research; consistency of source and purity should be monitored | |
Insulin | Core component of defined culture systems | Suitable for promoting glucose uptake, maintaining metabolism, and supporting proliferation of some cell types; one of the important components of ITS-type supplementation systems | Excessive levels may alter metabolic state and insulin/IGF-related signaling background | |
Sodium selenite | Trace element supplement | Suitable for providing antioxidant-related trace element support in chemically defined systems and commonly used together with insulin and transferrin | The concentration window is narrow; excess may induce oxidative stress or cytotoxicity | |
Hydrocortisone | Hormonal defined supplement | Suitable for epithelial cells, some primary cells, and hormone-responsive models, regulating differentiation, barrier function, and stress responses | A strong background variable; in mechanistic studies it should be interpreted separately from conventional serum systems | |
Progesterone | Hormonal defined supplement | Suitable for hormone-related models, certain neuronal cells, and studies of steroid background control in defined culture systems | Appropriate for receptor and steroid-response studies and should not be added casually under undefined background conditions | |
Putrescine dihydrochloride | Polyamine supplement | Suitable for neuronal cells, stem cells, and some low-serum/serum-free systems, supporting proliferation and metabolic stability | More commonly used together with other defined components; standalone supplementation is of limited value | |
Linoleic acid | Lipid supplement | Suitable as a fatty acid supplement in chemically defined media to support membrane synthesis and lipid metabolism | Should be used together with albumin or a lipid carrier to improve solubility and delivery stability | |
Oleic acid | Lipid supplement | Suitable for lipid supplementation in serum-free and defined systems, often used to improve the culture stability of adherent cells and metabolically active cells | Fatty acid supplementation requires attention to oxidative stability and carrier compatibility | |
Ethanolamine | Phospholipid precursor supplement | Suitable for some chemically defined systems, supporting phospholipid synthesis and membrane renewal | More suitable for fine optimization of defined systems and should not be evaluated in isolation from the full formulation | |
Sodium pyruvate | Energy metabolism supplement | Suitable for low-serum, serum-free, and high-metabolic-demand cultures as an alternative carbon source and stress-buffering substrate | Often used to enhance metabolic buffering, but not a core substitute for serum support | |
HEPES | Buffer-stabilizing component | Suitable for improving pH stability in supplementation systems, especially under frequent handling, imaging, or CO2 fluctuation | Mainly a buffering enhancer and does not directly provide growth stimulation | |
L-Glutamine | Nitrogen source / energy metabolism component | Suitable for most cell culture systems, supporting nucleic acid synthesis, protein synthesis, and energy metabolism | A highly consumed component whose stability is strongly influenced by preparation and storage conditions |
Table 5 Serum and Functionalized Serum Products for Cell Culture
Catalog No. | Name | Grade and Purity | System Category | Suitable Research Directions / Uses |
Fetal Bovine Serum (Premium Grade) | Bioactive,for cell culture,sterile-filtered | Animal-derived serum system | Routine expansion of common cell lines, post-thaw recovery culture, low-density seeding, and establishment of baseline culture conditions | |
Fetal Bovine Serum (Excellence Grade) | BioReagent,for cell culture,sterile-filtered | Animal-derived serum system | Routine expansion of adherent/suspension cells, continuous passaging, and day-to-day culture requiring robust viability and proliferation support | |
Fetal Bovine Serum (Stem Cell & Primary Cell Qualified) | sterile-filtered,BioReagent,for cell culture | Animal-derived serum system | Early expansion and state maintenance of stem cells and primary cells, especially in culture settings requiring strong support for attachment, survival, and stress buffering | |
Calf serum | BioReagent, sterile | Animal-derived serum system | Routine expansion of adherent cell lines, cost-sensitive basal culture supplementation, and initial condition screening | |
Calf Serum (For cell culture) | BioReagent, endotoxin tested, Mycoplasma free, for NA electrophoresis, sterile | Animal-derived serum system | Routine cell culture with tighter contamination control requirements, basic method development, and daily expansion | |
Newborn Calf Serum | BioReagent, sterile | Animal-derived serum system | Basal culture of primary or relatively sensitive cells, recovery of cell status, and routine expansion | |
Adult Bovine Serum | BioReagent, sterile | Animal-derived serum system | Basal expansion of relatively robust cell lines, culture condition screening, and cost-oriented routine culture | |
Horse Serum | BioReagent, sterile | Animal-derived serum system | Maintenance and differentiation-related culture of neurons, skeletal muscle cells, and some primary cells | |
Horse Serum | BioReagent, sterile | Functionalized serum system | Culture of complement-sensitive cells, selected immune-related systems, and culture settings requiring reduced complement activity | |
Rabbit Serum | BioReagent, sterile | Animal-derived serum system | Culture of rabbit-derived primary cells or tissue-derived cells and construction of homologous supplementation systems | |
New Zealand Rabbit Serum | BioReagent, sterile | Animal-derived serum system | Culture of New Zealand rabbit-derived cells or tissue models, with homologous serum supplementation for state maintenance | |
Rat Serum | BioReagent, sterile, >55 mg protein/mL,0.22 µm filtered | Animal-derived serum system | Homologous supplementation for rat primary cells, hepatocytes, neurons, and other rodent model cell cultures | |
Mouse Serum | BioReagent, sterile, ≥30.0 mg/ml,0.22 µm filtered | Animal-derived serum system | Homologous supplementation for mouse primary cells, immune cells, and tumor model cell cultures | |
ICR(CD-1) Mouse Serum | BioReagent, sterile | Animal-derived serum system | Culture models based on ICR(CD-1)-derived primary cells, embryo-related cells, and strain-matched systems | |
C57BL/6J Mouse Serum | BioReagent, sterile | Animal-derived serum system | Culture of C57BL/6J-derived immune cells, primary cells, and disease model-related cells | |
Porcine serum | BioReagent, sterile | Animal-derived serum system | Porcine cell culture, veterinary-related models, and early-stage virology or tissue engineering studies | |
Bama Miniature Pig Serum | BioReagent, sterile | Animal-derived serum system | Cell culture from miniature pig models, translational preclinical animal models, and comparative medicine studies | |
Beagle Dog Serum | BioReagent, sterile | Animal-derived serum system | Canine cell culture, pharmacology/toxicology evaluation, and veterinary cell model studies | |
Rhesus monkey serum | BioReagent, sterile | Animal-derived serum system | Culture of non-human primate-derived cells, infection studies, and preclinical translational evaluation models | |
Cynomolgus Monkey Serum | BioReagent, sterile | Animal-derived serum system | Culture of non-human primate-derived cells, pharmacodynamic/toxicology bridging studies, and high-similarity model systems | |
Goat Serum | - | Animal-derived serum system | Goat-derived cell culture, ruminant-related cell models, and establishment of homologous supplementation systems | |
Sheep Serum | BioReagent, sterile | Animal-derived serum system | Culture of sheep-derived cells, ruminant models, and maintenance of tissue-derived cell cultures | |
Guinea Pig Serum | sterile-filtered, BioReagent | Animal-derived serum system | Homologous supplementation for guinea pig-derived cell culture and immune- or infection-related animal models | |
Chicken Serum | BioReagent, sterile | Animal-derived serum system | Avian cells, embryonic cells, and virology-related culture systems | |
Fish serum | BioReagent, sterile | Animal-derived serum system | Fish cells, aquatic organism models, and culture studies under lower-temperature conditions | |
Donkey Serum | BioReagent, sterile | Animal-derived serum system | Donkey-derived cell culture, comparative studies in equine-related animals, and homologous supplementation culture | |
Feline Serum | BioReagent, sterile | Animal-derived serum system | Feline cell culture, veterinary virology, and pharmacology-related model studies | |
Exosome-Free FBS | sterile, BioReagent, for cell culture | Functionalized serum system | Exosome, extracellular vesicle, and secretome studies, as well as culture experiments requiring reduced vesicle background from serum | |
Charcoal-Stripped Fetal Bovine Serum | sterile-filtered,BioReagent,for cell culture,Endotoxin ≤9 EU/mL; Protein 30–45 g/L; Osmolality 250–330 mOsm/kg; Free thyroid hormone <2 pmol/L | Functionalized serum system | Hormone receptor, nuclear receptor, and steroid signaling studies, including ligand add-back or background-depletion experiments | |
Low IgG Fetal Bovine Serum | BioReagent,for cell culture,sterile-filtered | Functionalized serum system | Immunology studies, antibody-related functional research, and culture systems sensitive to Fc receptor or immunoglobulin background | |
Tetracycline-Free Fetal Bovine Serum | sterile-filtered,BioReagent,for cell culture,Tetracycline ≤1 ppb; Protein 30–45 g/L; Osmolality 250-330 mOsm/kg | Functionalized serum system | Tetracycline-inducible expression systems, tetracycline-responsive gene regulation, and culture requiring minimal antibiotic background | |
Dialyzed Fetal Bovine Serum | sterile-filtered,BioReagent,for cell culture,Glucose <50 mg/L; Endotoxin ≤9 EU/mL; Protein 30–45 g/L; Osmolality 250–330 mOsm/kg | Functionalized serum system | Metabolism studies, nutrient-dependency experiments, isotope tracing, and small-molecule supplementation/depletion designs |
Selection of a cell culture supplementation system should not be reduced to a simple comparison of proliferation rate or operational convenience. Animal-derived serum, functionalized serum, and non-animal-derived culture supplementation systems are suited to different research objectives, different requirements for background control, and different process stages. A more rational strategy is to establish a matched supplementation system on the basis of cell type and downstream experimental demands, with coordinated emphasis on proliferation support, phenotypic stability, and background interpretability.
For more related articles, please see below:
